BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 32199989)

  • 1. Qingda granule inhibits angiotensin Ⅱ induced VSMCs proliferation through MAPK and PI3K/AKT pathways.
    Yu N; Shen A; Chu J; Huang Y; Zhang L; Lin S; Cai Q; Sankararaman S; Sferra TJ; Chen Y; Peng J
    J Ethnopharmacol; 2020 Aug; 258():112767. PubMed ID: 32199989
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Qingda granule attenuates angiotensin II-induced cardiac hypertrophy and apoptosis and modulates the PI3K/AKT pathway.
    Cheng Y; Shen A; Wu X; Shen Z; Chen X; Li J; Liu L; Lin X; Wu M; Chen Y; Chu J; Peng J
    Biomed Pharmacother; 2021 Jan; 133():111022. PubMed ID: 33378940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antihypertensive and Vasodilatory Effects of Qingda Granules by Suppression of Calcium Influx and the AKT Pathway.
    Huang Y; Wu X; Wu M; Chu J; Yu N; Shen A; Shen Z; Chen Y; Peng J
    J Cardiovasc Pharmacol; 2019 Dec; 74(6):549-557. PubMed ID: 31809404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Qingxuan Jiangya Decoction Reverses Vascular Remodeling by Inducing Vascular Smooth Muscle Cell Apoptosis in Spontaneously Hypertensive Rats.
    Xiao F; He F; Chen H; Lin S; Shen A; Chen Y; Chu J; Peng J
    Molecules; 2016 Jul; 21(7):. PubMed ID: 27455221
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Qingxuan Jiangya Decoction () Prevents Blood Pressure Elevation and Ameliorates Vascular Structural Remodeling via Modulating TGF-β 1/Smad Pathway in Spontaneously Hypertensive Rats.
    He F; Chu JF; Chen HW; Lin W; Lin S; Chen YQ; Peng J; Chen KJ
    Chin J Integr Med; 2020 Mar; 26(3):180-187. PubMed ID: 31883057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Qingda Granule Attenuates Angiotensin II-Induced Blood Pressure and Inhibits Ca
    Wu M; Wu X; Cheng Y; Shen Z; Chen X; Xie Q; Chu J; Li J; Liu L; Wei L; Long L; Cai Q; Peng J; Shen A
    Front Pharmacol; 2021; 12():688877. PubMed ID: 34393778
    [No Abstract]   [Full Text] [Related]  

  • 7. Qingda granule attenuates cardiac fibrosis via suppression of the TGF-β1/Smad2/3 signaling pathway in vitro and in vivo.
    Chen X; Long L; Cheng Y; Chu J; Shen Z; Liu L; Li J; Xie Q; Liu H; Wu M; Chen Y; Peng J; Shen A
    Biomed Pharmacother; 2021 May; 137():111318. PubMed ID: 33556875
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Qingda granules attenuate hypertensive cardiac remodeling and inflammation in spontaneously hypertensive rats.
    Wu X; Shen A; Bao L; Wu M; Lin X; Wang H; Chen Y; Cai Q; Lin S; Zhou X; Lu Y; Peng M; Chen D; Chu J; Peng J
    Biomed Pharmacother; 2020 Sep; 129():110367. PubMed ID: 32559624
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention of systemic inflammation and neuroprotective effects of Qingda granules against angiotensin II-mediated hypertension.
    Zhang L; Cai QY; Lin S; Jia BB; Ye RZ; Wang H; Bao LY; Chen YQ; Chu JF; Peng J
    Pak J Pharm Sci; 2020 Jan; 33(1(Spec)):469-479. PubMed ID: 32173645
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alamandine attenuates angiotensin II-induced vascular fibrosis via inhibiting p38 MAPK pathway.
    Yang C; Wu X; Shen Y; Liu C; Kong X; Li P
    Eur J Pharmacol; 2020 Sep; 883():173384. PubMed ID: 32707188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Qingda granule ameliorates vascular remodeling and phenotypic transformation of adventitial fibroblasts via suppressing the TGF-β1/Smad2/3 pathway.
    Wu M; Zhang S; Zhang W; Zhou Y; Guo Z; Fang Y; Yang Y; Shen Z; Lian D; Shen A; Peng J
    J Ethnopharmacol; 2023 Sep; 313():116535. PubMed ID: 37100260
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Calcium/calmodulin-dependent kinase II inhibition in smooth muscle reduces angiotensin II-induced hypertension by controlling aortic remodeling and baroreceptor function.
    Prasad AM; Morgan DA; Nuno DW; Ketsawatsomkron P; Bair TB; Venema AN; Dibbern ME; Kutschke WJ; Weiss RM; Lamping KG; Chapleau MW; Sigmund CD; Rahmouni K; Grumbach IM
    J Am Heart Assoc; 2015 Jun; 4(6):e001949. PubMed ID: 26077587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impaired peroxisome proliferator-activated receptor-gamma contributes to phenotypic modulation of vascular smooth muscle cells during hypertension.
    Zhang L; Xie P; Wang J; Yang Q; Fang C; Zhou S; Li J
    J Biol Chem; 2010 Apr; 285(18):13666-77. PubMed ID: 20212046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiotensin II-induced histone deacetylase 5 phosphorylation, nuclear export, and Egr-1 expression are mediated by Akt pathway in A10 vascular smooth muscle cells.
    Truong V; Jain A; Anand-Srivastava MB; Srivastava AK
    Am J Physiol Heart Circ Physiol; 2021 Apr; 320(4):H1543-H1554. PubMed ID: 33606583
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of Xin-Ji-Er-Kang formula on 2K1C-induced hypertension and cardiovascular remodeling in rats.
    Guo K; Lan CZ; Yu TT; Huang LL; Wang XH; Pan C; Gao S
    J Ethnopharmacol; 2014 Sep; 155(2):1227-35. PubMed ID: 25063306
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Qingda Granule Attenuates Angiotensin II-Induced Renal Apoptosis and Activation of the p53 Pathway.
    Long L; Zhang X; Wen Y; Li J; Wei L; Cheng Y; Liu H; Chu J; Fang Y; Xie Q; Shen A; Peng J
    Front Pharmacol; 2021; 12():770863. PubMed ID: 35222007
    [No Abstract]   [Full Text] [Related]  

  • 17. BCL6 Attenuates Proliferation and Oxidative Stress of Vascular Smooth Muscle Cells in Hypertension.
    Chen D; Zang YH; Qiu Y; Zhang F; Chen AD; Wang JJ; Chen Q; Li YH; Kang YM; Zhu GQ
    Oxid Med Cell Longev; 2019; 2019():5018410. PubMed ID: 30805081
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-Proliferative Effects of Rutin on OLETF Rat Vascular Smooth Muscle Cells Stimulated by Glucose Variability.
    Yu SH; Yu JM; Yoo HJ; Lee SJ; Kang DH; Cho YJ; Kim DM
    Yonsei Med J; 2016 Mar; 57(2):373-81. PubMed ID: 26847289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic infusion of ELABELA alleviates vascular remodeling in spontaneously hypertensive rats via anti-inflammatory, anti-oxidative and anti-proliferative effects.
    Ye C; Geng Z; Zhang LL; Zheng F; Zhou YB; Zhu GQ; Xiong XQ
    Acta Pharmacol Sin; 2022 Oct; 43(10):2573-2584. PubMed ID: 35260820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quyu Shengxin capsule (QSC) inhibits Ang-II-induced abnormal proliferation of VSMCs by down-regulating TGF-β, VEGF, mTOR and JAK-STAT pathways.
    Yu J; Li W; Zhao L; Qiao Y; Yu J; Huang Q; Yang Y; Xiao X; Guo D
    J Ethnopharmacol; 2021 Jul; 275():114112. PubMed ID: 33905820
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.